Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL381566 | 0.79 | LTA4H (0.57) | LTA4HSIGMAR1CA4HTTIDO1 | |
| SCHEMBL381509 | 0.79 | LTA4H (0.57) | LTA4HSIGMAR1CA4LDHAHTT | |
| SCHEMBL8156353 | 0.77 | LTA4H (0.55) | LTA4HSIGMAR1CA4KMT2ALDHA | |
| SCHEMBL380591 | 0.77 | LTA4H (0.55) | LTA4HSIGMAR1CA4LDHAHTT | |
| SCHEMBL14604190 | 0.77 | LTA4H (0.55) | LTA4HSIGMAR1CA4HTTIDO1 | |
| SCHEMBL1144423 | 0.76 | LTA4H (0.53) | LTA4HSIGMAR1CA4HTTIDO1 | |
| SCHEMBL28156449 | 0.75 | LTA4H (0.52) | LTA4HSIGMAR1CA4HTTIDO1 | |
| SCHEMBL28200982 | 0.75 | LTA4H (0.52) | LTA4HSIGMAR1CA4HTTIDO1 | |
| SCHEMBL3310342 | 0.73 | L3MBTL1 (0.44) | SIGMAR1MEN1KMT2AHTTIDO1 | |
| SCHEMBL27428118 | 0.73 | SLC6A4 (0.51) | LTA4HSLC6A4SIGMAR1CA4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3856738-A1 | PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Química Sintética, S.A. (ES) | 2021-08-04 | — | — | EP | claimed |
| WO-2020064818-A1 | PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Química Sintética, S.A. (ES) | 2020-04-02 | — | — | WO | claimed |
| EP-3856738-A1 | PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Química Sintética, S.A. (ES) | 2021-08-04 | — | — | EP | disclosed |
| WO-2020064818-A1 | PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | Química Sintética, S.A. (ES) | 2020-04-02 | — | — | WO | disclosed |
| EP-2812296-A1 | FIRST ROW METAL-BASED CATALYSTS FOR HYDOSILYLATION | The Regents of The University of California (US) | 2014-12-17 | — | — | EP | disclosed |
| WO-2013120057-A1 | FIRST ROW METAL-BASED CATALYSTS FOR HYDOSILYLATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-08-15 | — | — | WO | disclosed |
| EP-1735269-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED BETA AMINO ACID DERIVATIVES | Merck & Co., Inc. (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005097733-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED BETA AMINO ACID DERIVATIVES | MERCK & CO., INC. (US) | 2005-10-20 | — | — | WO | disclosed |